|
|
Article: Alleviating allergic rhinitis.(New drug information from the publishers of MPR)(Drug overview)
- Article from:
- Cortlandt Forum
- Article date:
- July 1, 2007
CopyrightCOPYRIGHT 2007 Haymarket Media, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Veramyst
Company: GlaxoSmithKline
Pharmacologic class: Corticosteroid
Active ingredient: Fluticasone furoate 27.5 [micro]g/spray; alcohol-free.
Indication: Seasonal and perennial allergic rhinitis.
Related newspaper, magazine, and journal articles:
|
|
Article: Intranasal corticosteroids for the treatment of perennial ...
Southern Medical Journal;
July 1, 2007 ;
700+ words
... ... others. The recent ARIA (Allergic Rhinitis and its Impact on Asthma) guidelines reclassified allergic rhinitis based on a patient's symptom ... treatment options available for perennial allergic rhinitis (PAR) with a focus on intranasal ...
|
|